WFDC2 and ovarian cancer: By FDR-adjusted two-sample t-tests, the mean levels of 38 of the 68 proteins differed significantly (p < 0.05) between the early stage (I-II) ovarian cancer and healthy samples (Table 2); seventeen of these proteins were elevated in the ovarian cancer samples compared to the healthy control samples, including CA125 and HE4.